{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:02:16Z","timestamp":1791820936348,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This brief review is devoted mainly to publications in the last 5 years dealing with health-related quality of life (QoL) after a diagnosis of endogenous hypercortisolism, due to pituitary-dependent Cushing\u2019s disease (CD) or any other cause of Cushing syndrome (CS). Despite improvement after treatment, persistent physical morbidity, neurocognitive problems like worse executive capacity and memory as well as stress intolerance, depressive symptoms and more anxiety, lead to long-term impairment of QoL.<\/jats:p>","DOI":"10.1007\/s11102-022-01245-9","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T11:05:01Z","timestamp":1656500701000},"page":"768-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Quality of life impairment after a diagnosis of Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7052-6436","authenticated-orcid":false,"given":"Susan M","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3864-0105","authenticated-orcid":false,"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/joim.13056","volume":"288","author":"M Piasecka","year":"2020","unstructured":"Piasecka M, Papakokkinou E, Valassi E, Santos A, Webb SM, de Vries F, Pereira AM, Ragnarsson O (2020) Psychiatric and neurocognitive consequences of endogenous hypercortisolism. J Intern Med 288:168\u2013182. doi: https:\/\/doi.org\/10.1111\/joim.13056","journal-title":"J Intern Med"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1210\/jc.2019-01054","volume":"104","author":"LHA Broersen","year":"2019","unstructured":"Broersen LHA, Andela CD, Dekkers OM, Pereira AM, Biermasz NR (2019) Improvement but No Normalization of Quality of Life and Cognitive Functioning After Treatment of Cushing Syndrome. J Clin Endocrinol Metab 104:5325\u20135337. doi: https:\/\/doi.org\/10.1210\/jc.2019-01054","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1210\/jc.2019-00749","volume":"104","author":"KE Frimodt-M\u00f8ller","year":"2019","unstructured":"Frimodt-M\u00f8ller KE, M\u00f8llegaard Jepsen JR, Feldt-Rasmussen U, Krogh J (2019) Hippocampal Volume, Cognitive Functions, Depression, Anxiety, and Quality of Life in Patients With Cushing Syndrome. J Clin Endocrinol Metab 104:4563\u20134577. doi: https:\/\/doi.org\/10.1210\/jc.2019-00749","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/cen.14568","volume":"95","author":"L Martel-Duguech","year":"2021","unstructured":"Martel-Duguech L, Alonso-Jim\u00e9nez A, Bascu\u00f1ana H, D\u00edaz-Manera J, Llauger J, Nu\u00f1ez-Peralta C, Montesinos P, Webb SM, Valassi E (2021) Prevalence of Sarcopenia after remission of hypercortisolism and its impact on HRQoL. Clin Endocrinol (Oxf) 95:735\u2013743. doi: https:\/\/doi.org\/10.1111\/cen.14568","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1245_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40265-017-0735-z","volume":"77","author":"A Santos","year":"2017","unstructured":"Santos A, Resmini E, Pascual JC, Crespo I, Webb SM (2017) Psychiatric Symptoms in Patients with Cushing\u2019s Syndrome: Prevalence, Diagnosis and Management. Drugs 77:829\u2013842. doi: https:\/\/doi.org\/10.1007\/s40265-017-0735-z","journal-title":"Drugs"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.beem.2021.101505","volume":"35","author":"M McBride","year":"2021","unstructured":"McBride M, Crespo I, Webb SM, Valassi E (2021) Quality of life in Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 35:101505. doi: https:\/\/doi.org\/10.1016\/j.beem.2021.101505","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1245_CR7","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s11136-020-02480-y","volume":"29","author":"SA Moyers","year":"2020","unstructured":"Moyers SA, Tiemensma J (2020) The association between physical activity, sleep, and quality of life in patients in bio-chemical remission from Cushing\u2019s syndrome. Qual Life Res 29:2089\u20132100. doi: https:\/\/doi.org\/10.1007\/s11136-020-02480-y","journal-title":"Qual Life Res"},{"key":"1245_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cen.13600","volume":"88","author":"E Valassi","year":"2018","unstructured":"Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, T\u00f3th M, Webb SM, Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price J, Wass JA, Papakokkinou E, Ragnarsson O (2018) ERCUSYN Study Group: Worse Health-Related Quality of Life at longterm follow-up in patients with Cushing\u2019s disease than patients with cortisol producing adenoma. Data from the ERCUSYN. Clin Endocrinol (Oxf) 88:787\u2013798. doi: https:\/\/doi.org\/10.1111\/cen.13600","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1210\/clinem\/dgab079","volume":"106","author":"D Bengtsson","year":"2021","unstructured":"Bengtsson D, Ragnarsson O, Berinder K, Dahlqvist P, Ed\u00e9n Engstr\u00f6m B, Ekman B, H\u00f6ybye C, Burman P, Wahlberget J (2021) Psychotropic drugs in patients with Cushing\u2019s disease before diagnosis and at long-term follow-up\u2014a nationwide study. J Clin Endocrinol Metab 106:1750\u20131760. doi: https:\/\/doi.org\/10.1210\/clinem\/dgab079","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR10","doi-asserted-by":"crossref","unstructured":"Ebbehoj A, S\u00f8ndergaard E, Jepsen J, Stochholm K, Svane L, Madsen HM, Poulsen M, J\u00f8rgensen PL (2022) J.O.L.: The socio-economic consequences of Cushing\u2019s syndrome: a nationwide cohort study. J. Clin. Endocrinol. Metab. In Press","DOI":"10.2139\/ssrn.4000566"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgz329","volume":"105","author":"L Martel-Duguech","year":"2020","unstructured":"Martel-Duguech L, Alonso-Jim\u00e9nez A, Bascu\u00f1ana H, D\u00edaz-Manera J, Llauger J, Nu\u00f1ez-Peralta C, Biagetti B, Montesinos P, Webb SM, Valassi E (2020) Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing\u2019s Syndrome. J Clin Endocrinol Metab 105:1\u201311. doi:https:\/\/doi.org\/10.1210\/clinem\/dgz329","journal-title":"J Clin Endocrinol Metab"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"bvab109","DOI":"10.1210\/jendso\/bvab109","volume":"5","author":"R Acree","year":"2021","unstructured":"Acree R, Miller CM, Abel BS, Neary NM, Campbell K, Nieman LK (2021) Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome. J Endocr Soc 5:bvab109. doi: https:\/\/doi.org\/10.1210\/jendso\/bvab109","journal-title":"J Endocr Soc"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"9014768","DOI":"10.1155\/2018\/9014768","volume":"9","author":"I Kreitschmann-Andermahr","year":"2018","unstructured":"Kreitschmann-Andermahr I, Siegel S, Gammel C, Campbell K, Edwin L, Grzywotz A, Kuhna V, Koltowska-H\u00e4ggstr\u00f6m M, M\u00fcller O, Buchfelder M, Kleist B (2018) Support Needs of Patients with Cushing\u2019s Disease and Cushing\u2019s Syndrome: Results of a Survey Conducted in Germany and the USA. Int J Endocrinol 9:9014768. doi: https:\/\/doi.org\/10.1155\/2018\/9014768","journal-title":"Int J Endocrinol"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13023-018-0958-4","volume":"13","author":"N Knoble","year":"2018","unstructured":"Knoble N, Nayroles G, Cheng C, Arnould B (2018) Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing\u2019s syndrome. Orphanet J Rare Dis 13:228. doi: https:\/\/doi.org\/10.1186\/s13023-018-0958-4","journal-title":"Orphanet J Rare Dis"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-20-0652","volume":"183","author":"F Albarel","year":"2020","unstructured":"Albarel F, Pellegrini I, Rahabi H, Baccou C, Gonin L, Rochette C, Vermalle M, Cuny T, Castinetti F, Brue T (2020) Evaluation of an individualized education program in pituitary diseases: a pilot study. Eur J Endocrinol 183:551\u2013559. doi: https:\/\/doi.org\/10.1530\/EJE-20-0652","journal-title":"Eur J Endocrinol"},{"key":"1245_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-16-1015","volume":"177","author":"CD Andela","year":"2017","unstructured":"Andela CD, Repping-Wuts H, Stikkelbroeck NMML, Pronk MC, Tiemensma J, Hermus AR, Kaptein AA, Pereira AM, Kamminga NGA, Biermasz NR (2017) Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial. Eur J Endocrinol 177:59\u201372. doi: https:\/\/doi.org\/10.1530\/EJE-16-1015","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01245-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T09:24:57Z","timestamp":1666430697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01245-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01245-9","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"21 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}